Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Novo Nordisk A/S: Status regarding Novo Nordisk's holding of its own shares (31 December 2017)


Posted on: 02 Jan 18

Bagsværd, Denmark, 2 January 2018 - In continuation of the company's announcements dated 9 August 2017 and 1 November 2017 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE: NVO) and its wholly-owned affiliates on 31 December 2017 owned 55,542,054 of its own B shares of DKK 0.20, corresponding to a total nominal value of DKK 11,108,411 or 2.2% of the total share capital.

In the fourth quarter of 2017 a total of 13,925,270 B shares were repurchased, and 4,329 B shares were disposed to employees in connection with employee incentive programmes.

Further information

Media:    
Anne Margrethe Hauge +45 4442 3450 amhg@novonordisk.com
Ken Inchausti (US) +1 609 786 8316 kiau@novonordisk.com
     
Investors:    
Peter Hugreffe Ankersen +45 3075 9085 phak@novonordisk.com
Hanna Ögren +45 3079 8519 haoe@novonordisk.com
Anders Mikkelsen +45 3079 4461 armk@novonordisk.com
Christina Kjær +45 3079 3009 cnje@novonordisk.com
Kasper Veje (US) +1 609 235 8567 kpvj@novonordisk.com

 

Company announcement no. 1/2018

 

Attachments:

http://www.globenewswire.com/NewsRoom/AttachmentNg/016806e1-14be-44aa-9757-079f0883e332

GlobeNewswire
globenewswire.com

Last updated on: 02/01/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.